The Europe DNA digital data storage market is expected to grow from US$ 15.35 million in 2021 to US$ 459.57 million by 2028; it is estimated to grow at a CAGR of 62.5% from 2021 to 2028.
Market players associated with DNA data storage are actively exploring possible innovative technologies to facilitate research and medical care. Biomarkers have extensive applications in personalized cancer therapy. Moreover, market players are exploring advanced methods and technologies for diagnostic applications. For instance, in April 2021, IMAGEENS—a Paris-based medical artificial intelligence (AI) startup—expedited the development and commercialization of ArtFun+, an artificial intelligence software and its prognostic biomarkers for cardiovascular imaging, and raised funding of EUR 1.2 million for the same. Several innovative approaches by market players are expected to open up new scope for the Europe market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive theEurope DNA digital data storage market. The Europe DNA digital data storage market is expected to grow at a good CAGR during the forecast period.
Europe DNA Digital Data Storage Market Revenue and Forecast to 2028 (US$ million)
Europe DNA Digital Data Storage Market Segmentation
The Europe DNA digital data storage market is segmented based on sequencing, application, end user, and country. Based on sequencing, the Europe DNA digital data storage market is segmented into synthesis sequencing, ion semiconductor sequencing, chain termination sequencing, nanopore sequencing, and ligation sequencing. The synthesis sequencing segment dominated the Europe DNA digital data storage market in 2020, and the nanopore sequencing segment is expected to be the fastest-growing segment during the forecast period. Based on application, the Europe DNA digital data storage market is segmented into diagnostic research, personalized medicine, and others. The diagnostic research segment dominated the Europe DNA digital data storage market in 2020, and the same segment is expected to be the fastest-growing segment during the forecast period. Based on end user, the Europe DNA digital data storage market is segmented into hospitals and clinics, pharmaceutical and biotechnology companies, academic and research institutes, and others. The academic and research institutes segment dominated the Europe DNA digital data storage market in 2020. The same segment is expected to be the fastest-growing segment during the forecast period. Based on country, the Europe DNA digital data storage market has been segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Agilent Technologies, Inc.; DNA Script; Evonetix.; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Microsoft Corporation; Quantum Corporation; and Twist Bioscience are among the leading companies in the Europe DNA digital data storage market.
Europe DNA Digital Data Storage Market Strategic Insights
Europe DNA Digital Data Storage Market Report Highlights
| Report Attribute | Details |
| Market size in 2021 | US$ 15.35 Million |
| Market Size by 2028 | US$ 459.57 Million |
| CAGR (2021 - 2028) | 62.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Sequencing
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
Europe DNA Digital Data Storage Market Country and Regional Insights
